Quinic acid derivatives inhibit dengue virus replication in vitro

Virology Journal

Volumn 12, Issue 1, 2015, Pages

  Zanello, Paula Rodrigues ^a   Koishi, Andrea Cristine ^a   Rezende, Celso De Oliveira ^b   Oliveira, Larissa Albuquerque ^b   Pereira, Adriane Antonia ^b   De Almeida, Mauro Vieira ^b   Duarte Dos Santos, Claudia Nunes ^a   Bordignon, Juliano ^a  

^a INSTITUTO CARLOS CHAGAS   (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Antivirals; Dengue; Quinic acid; Replication

Indexed keywords

ANTIVIRUS AGENT; QUINIC ACID; QUINIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; DRUG SAFETY; DRUG SCREENING; HEPATOCELLULAR CARCINOMA CELL LINE; HUH7.5 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; VIROGENESIS; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; LIVER CELL; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MOLECULAR MODEL; MOSQUITO; PHYSIOLOGY;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL SURVIVAL; CULICIDAE; DENGUE VIRUS; HEPATOCYTES; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MODELS, MOLECULAR; MOLECULAR STRUCTURE; QUINIC ACID; VIRUS REPLICATION;

EID: 84951814065     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-015-0443-9     Document Type: Article

References (44)

1. OMS. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. New edition. France; WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland. 2009.
2. PAHO. General Information: Dengue. 2014. http://www.paho.org/hq/index.php?option=com-content&view=article&id=4493&Itemid=40232&lang=en. Access date: 11/12/2015.
3. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504-7.
4. Chan Y, Ho B, Chan K. Aedes aegypti (L.) and Aedes albopictus (Skuse) in Singapore City. 5. Observations in relation to dengue haemorrhagic fever. Bull World Health Organ. 1971;44:651-7.
5. Kalitzky M, Borowski P. Molecular Biology of the Flavivirus, 1st edition. Horizon Bioscience, Norfolk, United Kindom, 2006.
6. Halstead S. Dengue (Tropical Medicine Science and Practice). 5th ed. London: Imperial College Press; 2008.
7. Henchal E a, Putnak JR. The dengue viruses. Clin Microbiol Rev. 1990;3:376-96.
8. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell. 2002;108:717-25.
9. Maramorosch K. Structures and Mechanisms in Flavivirus Fusion. In Advances in Virus Research, 55th edition, Chapter 5. Academic Press, Harcourt Place, 32 Jamestown Road, London, United Kindom, 2000.
10. FUNASA. Dengue: Diagnóstico E Manejo Clínico. Ministério da Saúde, Fundação Nacional da Saúde, Setor de Autarquias Sul Quadra 4, Brasília, Brazil. 2002
11. Ruzek D. Flavivirus Encephalitis. In: Smith D, editor. Encephalitic Flaviviruses. 2011.
12. de Maria C, Trugo L, Mariz M. The Content of Individual Caffeoylquinic Acids in Edible Vegetables. J Food Compos Anal. 1999;12:289-92.
13. Barco AA, Benettia S, De Risib C, Marchettib P, Pollinib GP, Zaniratob V. D-(-)-Quinic acid: a chiron store for natural product synthesis. Tetrah. Asymm. 1997;8(21):3515-3545.
14. Federspiel M, Fischer R, Hennig M, Mair H-J, Oberhauser T, Rimmler G, et al. Industrial Synthesis of the Key Precursor in the Synthesis of the Anti-Influenza Drug Oseltamivir Phosphate (Ro 64-0796/002, GS-4104-02): Ethyl (3R,4S,5S)-4,5-epoxy-3-(1-ethyl-propoxy)-cyclohex-1-ene-1-carboxylate. Org Process Res Dev. 1999;3:266-74.
15. dos Santos PA, Pereira DM, Farah A, Trugo LC, Neto DA, Radler F. Distribution of quinic acid derivatives and other phenolic compounds in Brazilian propolis. Zeitschrift fur Naturforsch - Sect C J Biosci. 2003;58:590-3.
16. McDougall B, King PJ, Wu BW, Hostomsky Z, Reinecke MG, Robinson WE. Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase. Antimicrob Agents Chemother. 1998;42:140-6.
17. Kamng'ona A, Moore JP, Lindsey G, Brandt W. Inhibition of HIV-1 and M-MLV reverse transcriptases by a major polyphenol (3,4,5 tri-O-galloylquinic acid) present in the leaves of the South African resurrection plant, Myrothamnus flabellifolia. J Enzyme Inhib Med Chem. 2011;26:843-53.
18. Rezende Júnior COR, Verde SC, Rezende C a M, Caneschi W, Couri MRC, McDougall BR, et al. Synthesis and HIV-1 Inhibitory Activities of Dicaffeoyl and Digalloyl Esters of Quinic Acid Derivatives. Curr Med Chem. 2013;20:724-33.
19. Wang G-F, Shi L-P, Ren Y-D, Liu Q-F, Liu H-F, Zhang R-J, et al. Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro. Antiviral Res. 2009;83:186-90.
20. Ikeda K, Tsujimoto K, Uozaki M, Nishide M, Suzuki Y, Koyama AH, et al. Inhibition of multiplication of herpes simplex virus by caffeic acid. Int J Mol Med. 2011;28:595-8.
21. Rezende CO, Rigotto C, Caneschi W, Rezende C a M, Le Hyaric M, Couri MRC, et al. Anti-HSV-1 and antioxidant activities of dicaffeoyl and digalloyl esters of quinic acid. Biomed Prev Nutr. 2014;4:35-8.
22. Cinkilic N, Cetintas SK, Zorlu T, Vatan O, Yilmaz D, Cavas T, et al. Radioprotection by two phenolic compounds: chlorogenic and quinic acid, on X-ray induced DNA damage in human blood lymphocytes in vitro. Food Chem Toxicol. 2013;53:359-63.
23. Soh Y, Kim J-A, Sohn NW, Lee KR, Kim SY. Protective effects of quinic acid derivatives on tetrahydropapaveroline-induced cell death in C6 glioma cells. Biol Pharm Bull. 2003;26:803-7.
24. Zeng K, Thompson KE, Yates CR, Miller DD. Synthesis and biological evaluation of quinic acid derivatives as anti-inflammatory agents. Bioorg Med Chem Lett. 2009;19:5458-60.
25. Yates C, Zeng K, Miller D, Thompson K. Anti-inflammatory quinic acid derivatives for oral administration. 2007.
26. Thompson K, Zeng K, Wilson C, Gaber M, Miller D, Yates C. Quinic Acid Derivative KZ-14 Exhibits Radiomitigating Activity in Preclinical Models of Radiation Injury. Drug Dev Res. 2014;75:29-36.
27. Sheng Y, Åkesson C, Holmgren K, Bryngelsson C, Giamapa V, Pero RW. An active ingredient of Cat's Claw water extracts: Identification and efficacy of quinic acid. J Ethnopharmacol. 2005;96:577-84.
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J lmmunological Methods. 1983;65:55-63.
29. Repetto G, del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc. 2008;3:1125-31.
30. Chiba K, Kawakami K, Tohyama K. Simultaneous evaluation of cell viability by neutral red, MTT and crystal violet staining assays of the same cells. Toxicol Vitr. 1998;12:251-8.
31. Kwon HC, Jung CM, Shin CG, Lee JK, Choi SU, Kim SY, et al. A new caffeoyl quinic acid from aster scaber and its inhibitory activity against human immunodeficiency virus-1 (HIV-1) integrase. Chem Pharm Bull (Tokyo). 2000;48:1796-8.
32. Ojwang JO, Wang Y-H, Wyde PR, Fischer NH, Schuehly W, Appleman JR, et al. A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals. Antiviral Res. 2005;68:163-72.
33. Koishi AC, Zanello PR, Bianco ÉM, Bordignon J, Duarte dos Santos CN. Screening of Dengue virus antiviral activity of marine seaweeds by an in situ enzyme-linked immunosorbent assay. PLoS One. 2012;7(12):e51089.
34. Fu Y, Chen Y-L, Herve M, Gu F, Shi P-Y, Blasco F. Development of a FACS-based assay for evaluating antiviral potency of compound in dengue infected peripheral blood mononuclear cells. J Virol Methods. 2014;196:18-24.
35. De Burghgraeve T, Kaptein SJ, Ayala-Nunez NV, Mondotte JA, Pastorino B, Printsevskaya SS, et al. An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro. PLoS One. 2012;7(5):e37244.
36. Li Y, But PPH, Ooi VEC. Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Frodin. Antiviral Res. 2005;68:1-9.
37. Suzuki R, de Borba L, Duarte dos Santos CN, Mason PW. Construction of an infectious cDNA clone for a Brazilian prototype strain of dengue virus type 1: characterization of a temperature-sensitive mutation in NS1. Virology. 2007;362:374-83.
38. Mosimann ALP, de Borba L, Bordignon J, Mason PW, dos Santos CND. Construction and characterization of a stable subgenomic replicon system of a Brazilian dengue virus type 3 strain (BR DEN3 290-02). J Virol Methods. 2010;163:147-52.
39. Ng CY, Gu F, Phong WY, Chen Y-L, Lim SP, Davidson A, et al. Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing. Antiviral Res. 2007;76:222-31.
40. Talarico LB, Pujol C a, Zibetti RGM, Faría PCS, Noseda MD, Duarte MER, et al. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Antiviral Res. 2005;66:103-10.
41. Cruz DJM, Koishi AC, Taniguchi JB, Li X, Milan Bonotto R, No JH, et al. High content screening of a kinase-focused library reveals compounds broadly-active against dengue viruses. PLoS Negl Trop Dis. 2013;7:e2073.
42. Desprès P, Frenkiel MP, Deubel V. Differences between cell membrane fusion activities of two dengue type-1 isolates reflect modifications of viral structure. Virology. 1993;196:209-19.
43. Rezende Jr C, Oliveira L, Oliveira B, Almeida C, Ferreira B, Hyaric M, et al. Synthesis and Antibacterial Activity of Alkylated Diamines and Amphiphilic Amides of Quinic Acid Derivatives. Chem Biol Drug Des. 2015;86(3):344-50.
44. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol. 1992;30:545-51.